IL1B and type 2 diabetes mellitus: Ameliorated renal dysfunction in type 2 diabetic mice, and protective effects against structural nephropathies. Downregulated the level of NF-κB p65 phosphorylation as well as lowered pro-inflammatory mediators such as TNF- α and IL-1β in diabetic mice.